학술논문
New-Onset Diabetes Mellitus in COVID-19: A Scoping Review
Review
Review
Document Type
Academic Journal
Author
Source
Diabetes Therapy. January 2024, Vol. 15 Issue 1, p33, 28 p.
Subject
Language
English
ISSN
1869-6953
Abstract
Author(s): Anca Pantea Stoian [sup.1] [sup.2], Ioana-Cristina Bica [sup.2], Teodor Salmen [sup.2], Wael Al Mahmeed [sup.3], Khalid Al-Rasadi [sup.4], Kamila Al-Alawi [sup.5], Maciej Banach [sup.6] [sup.7] [sup.8], Yajnavalka Banerjee [sup.9], [...]
Introduction The coronavirus disease 2019 (COVID-19) pandemic became superimposed on the pre-existing obesity and diabetes mellitus (DM) pandemics. Since COVID-19 infection alters the metabolic equilibrium, it may induce pathophysiologic mechanisms that potentiate new-onset DM, and we evaluated this issue. Method A systematic review of the literature published from the 1 January 2020 until the 20 July 2023 was performed (PROSPERO registration number CRD42022341638). We included only full-text articles of both human clinical and randomized controlled trials published in English and enrolling adults (age > 18 years old) with ongoing or preceding COVID-19 in whom hyperglycemia was detected. The search was based on the following criteria: '(new-onset diabetes mellitus OR new-onset DM) AND (COVID-19) AND adults'. Results Articles on MEDLINE (n = 70) and the Web of Science database (n = 16) were included and analyzed by two researchers who selected 20 relevant articles. We found evidence of a bidirectional relationship between COVID-19 and DM. Conclusions This link operates as a pathophysiological mechanism supported by epidemiological data and also by the clinical and biological findings obtained from the affected individuals. The COVID-19 pandemic raised the incidence of DM through different pathophysiological and psychosocial factors.
Introduction The coronavirus disease 2019 (COVID-19) pandemic became superimposed on the pre-existing obesity and diabetes mellitus (DM) pandemics. Since COVID-19 infection alters the metabolic equilibrium, it may induce pathophysiologic mechanisms that potentiate new-onset DM, and we evaluated this issue. Method A systematic review of the literature published from the 1 January 2020 until the 20 July 2023 was performed (PROSPERO registration number CRD42022341638). We included only full-text articles of both human clinical and randomized controlled trials published in English and enrolling adults (age > 18 years old) with ongoing or preceding COVID-19 in whom hyperglycemia was detected. The search was based on the following criteria: '(new-onset diabetes mellitus OR new-onset DM) AND (COVID-19) AND adults'. Results Articles on MEDLINE (n = 70) and the Web of Science database (n = 16) were included and analyzed by two researchers who selected 20 relevant articles. We found evidence of a bidirectional relationship between COVID-19 and DM. Conclusions This link operates as a pathophysiological mechanism supported by epidemiological data and also by the clinical and biological findings obtained from the affected individuals. The COVID-19 pandemic raised the incidence of DM through different pathophysiological and psychosocial factors.